Home » Neurochem Shares Collapse Again as Alzhemed Flounders
Neurochem Shares Collapse Again as Alzhemed Flounders
Canada’s Neurochem has seen its stock take a bashing for the second day running as the news that the firm’s investigational Alzheimer’s treatment has failed a late-stage trial takes effect.
PharmaTimes
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May